Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Cash from Financing Activities of $756421.0 for Q1 2026, up 44.48% quarter-over-quarter from $523550.0 in Q4 2025.
Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Nexalin Technology's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $756421.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $756421.0; the TTM figure through Mar 2026 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, up 14.48% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $756421.0, up from $523550.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $8.5 million in Q3 2022, with the low at -$200000.0 in Q1 2023.
- The 4-year median for Cash from Financing Activities is $261825.0 (2022), against an average of $1.6 million.
- Peak annual rise in Cash from Financing Activities reached 200100.0% in 2023, while the deepest fall reached 200100.0% in 2023.
- Nexalin Technology's Cash from Financing Activities stood at $8.5 million in 2022, then plunged by 102.35% to -$200000.0 in 2023, then jumped by 361.78% to $523550.0 in 2025, then surged by 44.48% to $756421.0 in 2026.
- Business Quant data shows NXL's Cash from Financing Activities at $756421.0 in Q1 2026, $523550.0 in Q4 2025, and -$200000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 | 138,365.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138,365.00 |
| Jun 30, 2026 | 138,365.00 |
| Mar 31, 2026 | 756,421.00 |
| Mar 31, 2026 | 756,421.00 |
| Dec 31, 2025 | 523,550.00 |
| Dec 31, 2025 | 523,550.00 |
| Mar 31, 2023 | -200,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Sep 30, 2022 | 8.52 Mn |
| Sep 30, 2022 | 8.52 Mn |
| Jun 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -5,000.00 |
| Mar 31, 2022 | 100.00 |
| Mar 31, 2022 | 100.00 |
| Dec 31, 2021 | 934,443.00 |
| Dec 31, 2021 | 934,443.00 |